- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of ARCH Venture Fund IX, L.P.
- Signature - Title
- ARCH Venture Partners IX, L.P. - its General Partner
- Location
- Chicago, IL
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by ARCH Venture Fund IX, L.P..
Follow Filing Activity
Follow ARCH Venture Fund IX, L.P. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of ARCH Venture Fund IX, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | Common Stock, par value $0.0001 per share | 17% | $163,630,594 | 46,093,125 | Robert Nelsen | 30 Sep 2025 | ||
| LYEL | Lyell Immunopharma, Inc. | Common Stock par value $0.0001 per share | 13% | $17,200,927 | 36,597,716 | Robert Nelsen | 31 Dec 2024 | ||
| LYEL | Lyell Immunopharma, Inc. | Common Stock par value $0.0001 per share | 13% | $44,807,053 | 2,759,072 | ARCH Venture Fund IX, L.P. | 30 Sep 2025 | ||
| VIR | Vir Biotechnology, Inc. | Common Stock, $0.0001 par value | 8.5% | $101,645,627 | 13,534,704 | Robert Nelsen | 27 Feb 2026 | ||
| BEAM | Beam Therapeutics Inc. | Common Stock par value $0.01 per share | 4.6% | $90,680,723 | 4,600,747 | 0% | Robert Nelsen | 31 Mar 2025 | |
| OMIC | Singular Genomics Systems, Inc. | Common Stock par value $0.0001 per share | 0% | $0 | 0 | ARCH Venture Fund IX, L.P. | 21 Feb 2025 |
Schedules 13D/G Reported by ARCH Venture Fund IX, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.